Exponent (NASDAQ:EXPO – Get Free Report) will release its earnings data after the market closes on Thursday, April 25th. Analysts expect Exponent to post earnings of $0.46 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.
Exponent (NASDAQ:EXPO – Get Free Report) last released its quarterly earnings data on Thursday, February 1st. The business services provider reported $0.41 earnings per share for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.03). Exponent had a net margin of 18.69% and a return on equity of 28.49%. The firm had revenue of $113.87 million during the quarter, compared to analysts’ expectations of $119.11 million. During the same period in the previous year, the firm posted $0.44 EPS. The firm’s quarterly revenue was up 1.1% on a year-over-year basis. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Exponent Stock Performance
EXPO opened at $79.65 on Tuesday. Exponent has a fifty-two week low of $64.61 and a fifty-two week high of $101.65. The company has a fifty day moving average of $79.35 and a two-hundred day moving average of $81.98. The stock has a market capitalization of $4.03 billion, a price-to-earnings ratio of 40.85 and a beta of 0.68.
Exponent Increases Dividend
Analyst Ratings Changes
A number of analysts have recently commented on the stock. StockNews.com raised shares of Exponent from a “sell” rating to a “hold” rating in a research note on Monday, March 4th. Truist Financial cut their target price on shares of Exponent from $110.00 to $95.00 and set a “buy” rating for the company in a research note on Friday, February 2nd.
Read Our Latest Report on EXPO
Insider Transactions at Exponent
In other news, insider Eric Guyer sold 3,367 shares of the business’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $78.49, for a total transaction of $264,275.83. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.20% of the company’s stock.
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading
- Five stocks we like better than Exponent
- What is the S&P/TSX Index?
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Financial Services Stocks Investing
- Merger or Not, Albertson’s Companies is a Good Buy
- Basic Materials Stocks Investing
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.